Patents by Inventor Michael Ranke

Michael Ranke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7041450
    Abstract: The present invention relates to a method and kit for diagnosing GH (growth hormone) deficiency, in particular isolated growth hormone deficiency II (IGHD II). The method comprises the steps of analysing the missense mutation G6191 to T in exon 4 of GH-1 which changes valine 110 to phenylalanine.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: May 9, 2006
    Assignee: Pharmacia AB
    Inventor: Michael Ranke
  • Publication number: 20060051810
    Abstract: A kit for diagnosis of autosomal dominantly inherited isolated growth hormone (GH) deficiency (IGHD II) in a patient sample comprises means for analyzing a patient sample for the presence or absence of a T at nucleotide position 6191 in exon 4 of the GH-1 gene.
    Type: Application
    Filed: November 8, 2005
    Publication date: March 9, 2006
    Inventor: Michael Ranke
  • Publication number: 20030027185
    Abstract: The present invention relates to a method and kit for diagnosing GH (growth hormone) deficiency, in particular isolated growth hormone deficiency II (IGHD II). The method comprises the steps of analysing the missense mutation G6191 to T in exon 4 of GH-1 which changes valine 110 to phenylalanine.
    Type: Application
    Filed: May 2, 2002
    Publication date: February 6, 2003
    Inventor: Michael Ranke